Significant advances have been made uncovering the factors that render neurons vulnerable in Parkinson's disease (PD). However, the critical pathogenic events leading to cell loss remain poorly understood, complicating the development of disease-modifying interventions. Given that the cardinal motor symptoms and pathology of PD involve the loss of dopamine (DA) neurons of the substantia nigra pars compacta (SNc), a majority of the work in the PD field has focused on this specific neuronal population. PD however, is not a disease of DA neurons exclusively: pathology, most notably in the form of Lewy bodies and neurites, has been reported in multiple regions of the central and peripheral nervous system, including for example the locus coerule...
Parkinson's disease (PD) is a neurodegenerative disease associated with progressive and inexorable l...
The characteristic motor symptoms of Parkinson disease (PD) are primarily the result of the progress...
α-synuclein (α-syn) pathology and loss of noradrenergic neurons in the locus coeruleus (LC) are amon...
Parkinson's disease is a neurodegenerative disorder that affects 1.5% of the global population over ...
Parkinson's disease (PD) is an incurable age-linked neurodegenerative disease with characteristic mo...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopamine (DA) ...
Parkinson disease (PD) is no longer considered a complex motor disorder characterized by Parkinsonis...
Parkinson's disease (PD) is the second most prevalent late-onset neurodegenerative disorder worldwid...
peer reviewedA specific set of brainstem nuclei are susceptible to degeneration in Parkinson’s disea...
Parkinson's disease is a highly debilitating disorder classically characterized by the degeneration ...
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder that results from th...
Parkinson’s disease (PD), with its characteristic loss of nigrostriatal dopaminergic neurons and dep...
Parkinson’s disease (PD) is the most frequently occurring movement disorder, with an increasing inci...
Parkinson’s disease (PD), with its characteristic loss of nigrostriatal dopaminergic neurons and dep...
Objective Neuronal loss in the substantia nigra pars compacta (SNpc) in Parkinson's disease (PD) ...
Parkinson's disease (PD) is a neurodegenerative disease associated with progressive and inexorable l...
The characteristic motor symptoms of Parkinson disease (PD) are primarily the result of the progress...
α-synuclein (α-syn) pathology and loss of noradrenergic neurons in the locus coeruleus (LC) are amon...
Parkinson's disease is a neurodegenerative disorder that affects 1.5% of the global population over ...
Parkinson's disease (PD) is an incurable age-linked neurodegenerative disease with characteristic mo...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopamine (DA) ...
Parkinson disease (PD) is no longer considered a complex motor disorder characterized by Parkinsonis...
Parkinson's disease (PD) is the second most prevalent late-onset neurodegenerative disorder worldwid...
peer reviewedA specific set of brainstem nuclei are susceptible to degeneration in Parkinson’s disea...
Parkinson's disease is a highly debilitating disorder classically characterized by the degeneration ...
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder that results from th...
Parkinson’s disease (PD), with its characteristic loss of nigrostriatal dopaminergic neurons and dep...
Parkinson’s disease (PD) is the most frequently occurring movement disorder, with an increasing inci...
Parkinson’s disease (PD), with its characteristic loss of nigrostriatal dopaminergic neurons and dep...
Objective Neuronal loss in the substantia nigra pars compacta (SNpc) in Parkinson's disease (PD) ...
Parkinson's disease (PD) is a neurodegenerative disease associated with progressive and inexorable l...
The characteristic motor symptoms of Parkinson disease (PD) are primarily the result of the progress...
α-synuclein (α-syn) pathology and loss of noradrenergic neurons in the locus coeruleus (LC) are amon...